Real-world experience of carfilzomib-associated cardiovascular adverse events: SEER-Medicare data set analysis

Rohit Bishnoi, Zhigang Xie, Chintan Shah, Jiang Bian, Hemant S. Murthy, John R. Wingard, Nosha Farhadfar

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)70-78
Number of pages9
JournalCancer Medicine
Volume10
Issue number1
DOIs
StatePublished - Jan 2021
Externally publishedYes

ASJC Scopus Subject Areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Keywords

  • cardiotoxicity
  • cardiovascular adverse events
  • carfilzomib
  • multiple myeloma
  • proteasome inhibitors

Cite this